New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization

References

• Erkoboni DF. Extrusion-spheronization as a granulation technique. In: Parikh DM, ed. Hanbook of pharmaceutical granulation technology. New York: Informa Healthcare USA; 2009:281–307
   Google Scholar
• Mastropietro DJ, Omidian H. Prevalence and trends of cellulosics in pharmaceutical dosage forms. Drug Dev Ind Pharm 2013;39:382–92
   PubMed Web of Science ®Google Scholar
• Shah RD, Kabadi M, Pope DG, Augsburger LL. Physicomechanical characterization of the extrusion-spheronization process. 2. Rheological determinants for successful extrusion and spheronization. Pharm Res 1995;12:496–507
   PubMed Web of Science ®Google Scholar
• Pinto JF, Buckton G, Newton JM. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronization. Int J Pharm 1992;83:187–96
   Web of Science ®Google Scholar
• Zimm KR, Schwartz JB, O’Connor RE. Drug release from a multiparticulate pellet system. Pharm Dev Tech 1996;1:37–42
   PubMedGoogle Scholar
• Otero-Espinar FJ, Luzardo-Alvarez A, Blanco-Mendez J. Non-MCC materials as extrusion-spheronization aids in pellets production. J Drug Del Sci Tech 2010;20:303–18
   Web of Science ®Google Scholar
• Dukic-Ott A, Thommes M, Remon JP, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm 2009;71:38–46
   PubMed Web of Science ®Google Scholar
• Fielden KE, Newton JM, Rowe RC. The influence of lactose particle-size on spheronization of extrudate processed by a ram extruder. Int J Pharm 1992;81:205–24
   Web of Science ®Google Scholar
• Ku CC, Joshi YM, Bergum JS, Jain NB. Bead manufacture by extrusion spheronization – a statistical design for process optimization. Drug Dev Ind Pharm 1993;19:1505–19
   Web of Science ®Google Scholar
• Sousa JJ, Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232:91–106
   PubMed Web of Science ®Google Scholar
• Fielden KE, Newton JM, Rowe RC. The influence of moisture-content on spheronization of extrudate processed by a ram extruder. Int J Pharm 1993;97:79–92
   Web of Science ®Google Scholar
• Baert L, Fanara D, Remon JP, Massart D. Correlation of extrusion forces, raw-materials and sphere characteristics. J Pharm Pharmacol 1992;44:676–8
   PubMed Web of Science ®Google Scholar
• Hasznos L. The effect of drug load, type of microcrystalline cellulose and lactose particle size on selected pellet characteristics. Pharmazie 1998;53:423--4
   Web of Science ®Google Scholar
• Goyanes A, Souto C, Martínez-Pacheco R. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization. Pharm Dev Tech 2010;15:626–35
   PubMed Web of Science ®Google Scholar
• Goyanes A, Souto C, Martínez-Pacheco R. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization. Eur J Pharm Biopharm 2011;79:658–63
   PubMed Web of Science ®Google Scholar
• Goyanes A, Souto C, Martínez-Pacheco R. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets. Drug Dev Ind Pharm 2011;37:825–31
   PubMed Web of Science ®Google Scholar
• Goyanes A, Souto C, Martínez-Pacheco R. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization. Pharm Dev Tech 2013;18:137–45
   PubMed Web of Science ®Google Scholar
• Souto C, Rodriguez A, Parajes S, Martínez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm 2005;61:94–9
   PubMed Web of Science ®Google Scholar
• Neumerkel O, Sakr A, Suss W. Studies of the production and testing of fluidized-bedrotor granules with modified release. Pharmazie 1999;54:837–9
   Web of Science ®Google Scholar
• Lovgren K, Bogentoft C. Influence of different disintegrants on dissolution rate and hardness of furosemide granules prepared by spheronization technique. Acta Pharm Suec 1981;18:108–9
   Google Scholar
• Schroder M, Kleinebudde P. Development of disintegrating pellets obtained from extrusion/spheronization. Pharm Sci 1995;1:415–18
   Google Scholar
• Zhao N, Augsburger LL. The influence of granulation on super disintegrant performance. Pharm Dev Tech 2006;11:47–53
   PubMed Web of Science ®Google Scholar
• El-Barghouthi M, Eftaiha A, Rashid I, et al. A novel superdisintegrating agent made from physically modified chitosan with silicon dioxide. Drug Dev Ind Pharm 2008;34:373–83
   PubMed Web of Science ®Google Scholar
• Gupta P, Nachaegari SK, Bansal AK. Improved excipient functionality by coprocessing. In: Katdare A, Chaubal MV, eds. Excipient development for pharmaceutical, biotechnology, and drug delivery systems. New York: Informa Healthcare; 2006:109–26
   Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. London: Pharmaceutical Press and American Pharmacists Association; 2009
   Google Scholar
• JRS PHARMA. Prosolv EASYtab. [Jun 2013]; Available at: http://www.jrs.de/Pharma/wEnglisch/produktinfo/productinfo_prosolv_easytab.shtml
   Google Scholar
• Hileman GA, Goskonda SR, Spalitto AJ, Upadrashta SM. A factorial approach to high-dose product development by an extrusion spheronization process. Drug Dev Ind Pharm 1993;19:483–91
   Web of Science ®Google Scholar
• JRS PHARMA. Prosolv ODT. [Jun 2013]; Available at: http://www.jrs.de/Pharma/wDeutsch/produktinfo/productinfo_prosolv_odt.shtml
   Google Scholar
• Pasic M, Betz G, Hadzidedic S, et al. Investigation and development of robust process for direct pelletization of lansoprazole in fluidized bed rotary processor using experimental design. J Drug Del Sci Tech 2010;20:367–76
   Web of Science ®Google Scholar
• Varma MV, Gardner I, Steyn SJ, et al. pH-dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Mol Pharmaceut 2012;9:1199–212
   PubMed Web of Science ®Google Scholar
• Ali SL. Nifedpine. In: Florey K, ed. Analytical profiles of drug substances. San Diego: Academic Press; 1990:221–88
   Google Scholar
• Granero GE, Longhi MR, Mora MJ, et al. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J Pharm Sci 2010;99:2544–56
   PubMed Web of Science ®Google Scholar
• Higgins JD, Gilmor TP, Martellucci SA, et al. Ibuprofen. In: Harry GB, ed. Analytical profiles of drug substances and excipients. San Diego and London: Academic Press; 2001:265–300
   Google Scholar
• Deppeler HP. Hydrochlorothiazide. In: Florey K, ed. Analytical profiles of drug substances. New York: Academic Press; 1981:405–41
   Google Scholar
• Exner HE, Linck E. Image analysis for characterization of size-distribution and shape-distribution of lead powders. Powder Met Int 1977;9:131–3
   Web of Science ®Google Scholar
• Avdeef A, Berger CM, Brownell C. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm Res 2000;17:85–9
   PubMed Web of Science ®Google Scholar
• Carr R. Chemical engineering. New York: McGraw-Hill; 1965
   Google Scholar
• Gomez-Amoza JL, Martinez-Pacheco R. Influence of microstructure on drug release from extrusion-spheronization pellets. J Drug Del Sci Tech 2010;20:319–25
   Web of Science ®Google Scholar
• Roblegg E, Schrank S, Griesbacher M, et al. Use of the direct compression aid Ludiflash® for the preparation of pellets via wet extrusion/spheronization. Drug Dev Ind Pharm 2011;37:1231–43
   PubMed Web of Science ®Google Scholar